Beachwood, OH, United States of America

Helen Moinova

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Helen Moinova: Pioneering Advances in Esophageal Cancer Detection

Introduction

Helen Moinova, an innovative inventor based in Beachwood, Ohio, has made significant contributions to the field of medical diagnostics. With three patents to her name, she is recognized for her groundbreaking work in identifying genomic markers associated with esophageal neoplasias and metaplasias. Her research promises to enhance early detection and treatment strategies for esophageal cancers, improving patient outcomes.

Latest Patents

Moinova's latest patents focus on methods and compositions for detecting esophageal neoplasias and/or metaplasias. The disclosure outlines novel methods for identifying genomic loci, such as vimentin and SqBE18, which are differentially methylated in conditions like Barrett's esophagus and esophageal cancers. The identification of these methylated genomic loci has numerous applications, including characterizing disease risk, predicting therapy responsiveness, non-invasive diagnosis, and treatment for individuals with gastrointestinal metaplasias and neoplasias.

Career Highlights

Throughout her career, Helen Moinova has collaborated with prestigious institutions, gaining experience and expertise in her field. She has worked with notable organizations such as Case Western Reserve University and the Massachusetts Institute of Technology. Her work not only exemplifies her commitment to scientific advancement but also highlights her role in pushing the boundaries of cancer research.

Collaborations

Moinova has collaborated with esteemed colleagues, including Sanford D. Markowitz and Amitabh Chak. Their combined efforts have contributed to the advancements in understanding the molecular underpinnings of esophageal conditions, paving the way for innovative diagnostic methods.

Conclusion

Helen Moinova's impact on the field of esophageal cancer detection is substantial. Her patents and collaborative efforts signify a remarkable journey of innovation and dedication. As she continues to advance research in this critical area, her work stands to benefit countless patients confronting gastrointestinal diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…